Charles Schwab Investment Management Inc Abeona Therapeutics Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 24,457 shares of ABEO stock, worth $157,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,457
Previous 23,850
2.55%
Holding current value
$157,013
Previous $132,000
12.12%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ABEO
# of Institutions
77Shares Held
27.8MCall Options Held
556KPut Options Held
34.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$23.7 Million0.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.51MShares$22.5 Million0.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.69MShares$17.3 Million0.02% of portfolio
-
Western Standard LLC Los Angeles, CA2.28MShares$14.6 Million6.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$13 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $38.2M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...